The global spirometer market is growing due to growing awareness about the advanced respiratory care therapeutic and monitoring devices, increasing home use of spirometers, and technological advancement in respiratory care devices. The diagnostic application dominates the application segment of the market, as it is mainly used for the diagnosis of various respiratory diseases. Based on products, the table-top spirometer segment led the market, as the device is compact in nature.  The unexplored market in the spirometer industry of the developing economies is creating ample growth opportunities for the global market.

Spirometer is an instrument used to assess lung function by measuring the volume of air inhaled and exhaled from the lungs after maximum inhalation by patient. It helps in the diagnosis of various respiratory diseases, such as chronic obstructive lung disease (COPD), asthma, bronchitis and emphysema, other conditions that affect breathing, and for screening in occupational environment. It is primarily used for the analysis of prognosis of the respiratory diseases, and analysis of lung function before surgery. Hand-held, table-top and desktop spirometers are the major type of spirometers. Table-top is extensively used in clinics and hospitals. Hand-held are easy to use and are used in homecare and general practice by smokers and asthma patients. Moreover, desktop spirometers are used especially for the diagnosis of black lungs, tuberculosis, chronic obstructive diseases and other respiratory diseases. It is reliable for pre/post- bronchodilator use, with reversible analysis and automatic interpretation. It is used to measure forced vital capacity, peak expiratory flow, slow vital capacity, forced expired volume in one second and others.

Geographically, North America is expected to dominate the global market throughout the coming years, due to growing aging population and regulations to monitor patient’s respiratory status. In addition, the technological advancement in respiratory monitoring devices and increasing prevalence of respiratory diseases are also driving the growth of the North American market. Asia-Pacific is expected to be the fastest growing region in the market, due to refining healthcare infrastructure and large pool of patients in the region. In addition, the Asia-Pacific market is growing, due to increasing healthcare expenditure and increasing incidence of respiratory conditions in the emerging countries, such as India and China.

Some of the companies operating in the global spirometer market are Welch Allyn Inc., Schiller AG, Carefusion Corporation, NDD Medical Technologies Inc., Philips Healthcare, Cosmed, Midmark Corporation, Medical International Research, Futuremed, SDI Diagnostics, MGC Diagnostics Corporation, Nihon Kohden Corporation, Vitalograph, and Jones Medical Instrument Company.